|
BRMS1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.81366033302766E-12 |
| Normal-vs-Stage2 |
6.20799966988272E-10 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
1.419400E-01 |
| Stage1-vs-Stage3 |
7.90729999999851E-05 |
| Stage1-vs-Stage4 |
1.06889999995641E-06 |
| Stage2-vs-Stage3 |
1.602010E-01 |
| Stage2-vs-Stage4 |
3.514000E-02 |
| Stage3-vs-Stage4 |
4.162400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
7.04458713585154E-12 |
| Normal-vs-Asian |
7.232100E-04 |
| Caucasian-vs-AfricanAmerican |
7.637400E-01 |
| Caucasian-vs-Asian |
7.984000E-01 |
| AfricanAmerican-vs-Asian |
8.540400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62503344114384E-12 |
| Male-vs-Female |
2.049200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.88120013694993E-10 |
| Normal-vs-Age(41-60Yrs) |
1.63324909152607E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.11319999884785E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.509000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.919200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.124200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.857800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.931600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.873000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.548300E-02 |
| Normal-vs-Grade 2 |
2.03637107176746E-12 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
1.148950E-01 |
| Grade 1-vs-Grade 3 |
4.616600E-03 |
| Grade 1-vs-Grade 4 |
2.4321999999577E-06 |
| Grade 2-vs-Grade 3 |
5.819700E-04 |
| Grade 2-vs-Grade 4 |
1.19580000346176E-08 |
| Grade 3-vs-Grade 4 |
4.803200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.73399961056475E-10 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
1.97925999999571E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.67665881178891E-12 |
| N0-vs-N1 |
1.298820E-03 |
|
|
